Emily Meehan

Associate

  • Emily Meehan
  • Phone: +1 215 979 7121

    Import to Address Book

  • Duane Morris LLP
    30 South 17th Street
    Philadelphia, PA 19103-4196
    USA

Emily Meehan practices in the area of corporate law, including representing independent trustees of mutual funds and ETFs. Ms. Meehan also represents clients in mergers and acquisitions and private equity transactions in the technology, life sciences and consumer products sectors. 

Ms. Meehan is a 2020 cum laude graduate of Temple University Beasley School of Law, where she was the recipient of the Jack M. Golden and Frieda Golden Prize, and a cum laude graduate of St. Joseph's University.

Admissions

  • Pennsylvania

Education

  • Temple University Beasley School of Law, J.D., cum laude, 2020
    - Recipient of the Jack M. Golden and Frieda Golden Prize
  • St. Joseph's University, B.A., cum laude, 2017

Experience

  • Duane Morris LLP
    - Associate, 2021-present

Representative Matters

  • Represented Strategic Underwriters International Inc. (SUI) in connection with its sale to NSM Insurance, an affiliate of the Carlyle Group; based in Doylestown, Pennsylvania, SUI offers commercial auto liability, general liability and workers compensation facultative reinsurance products, and they are a leader in the reinsurance business.

  • Represented American Racing and Entertainment, the owner and operator of Tioga Downs Casino Resort and Vernon Downs Casino Hotel, in its $175 million sale and leaseback of the real estate assets of Tioga Downs to Gaming and Leisure Properties, Inc. (NASDAQ: GLPI), a real estate investment trust focused on owning real estate property that is leased to gaming operators.

  • Represented Hover Energy, LLC, manufacturer/distributor of the Wind-Powered Microgrid™, featuring wind and solar energy generation and storage, in connection with its acquisition of all issued and outstanding membership interests in GreanLife Solar, LLC, a commercial solar development company d/b/a Shine Development Partners, and a leader in the solar energy solutions industry.

  • Represented Element Dental (fka Mid-Atlantic Dental), a portfolio company of a fund sponsored by SC Goldman, in connection with its merger with Sonrava Health (fka Western Dental), a portfolio company of a fund sponsored by New Mountain Capital; the merger created a diversified dental support organization (DSO) offering dental services through 572 offices in 20 states.

  • Advised Market Street Advisors, Inc. dba Archer®, a technology-enabled service provider to the investment management industry, in a leveraged recapitalization that included a growth investment by LLR Partners, the redemption of NewSpring Capital’s investment, a loan facility from Silicon Valley Bank and a corporate restructuring.

  • Advised CMS Technologies, Inc. dba Prevenio®, a leading provider of innovative food safety solutions primarily for protein and produce industries, in its $170 million acquisition by JBT Corporation (NYSE: JBT), a global technology solutions provider to high-value segments of the food and beverage industry.

  • Represented StoneMor Inc. in its sale of $400 million in senior secured notes to Jefferies LLC as initial purchaser in a Rule 144A private placement transaction; the notes were guaranteed by more than 125 StoneMor subsidiaries operating in 24 states and Puerto Rico.

  • Represented Allevi, Inc., a manufacturer of 3D bioprinters and bioinks trusted by leading researchers worldwide, in the $9.5 million sale of its business to 3D Systems (NYSE: DDD), a provider of 3D printing and digital manufacturing solutions.

  • Represented Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced pharmaceutical delivery technologies, development, and manufacturing solutions with market cap in excess of $17 billion, in its $80 million “carve-out” acquisition of the manufacturing and packaging operations of Acorda Therapeutics, Inc. (Nasdaq: ACOR), a neurological disorder therapy manufacturer and developer in Massachusetts, operating best-in-class spray drying capacity; the acquisition complemented Catalent’s status as a premier U.S.-based partner for companies across dry powder inhaled dose forms.